The Predictive QSAR Model for hERG Inhibitors Using Bayesian and Random Forest Classification Method

In this study, we have developed a ligand-based in-silico prediction model to classify chemical structures into hERG blockers using Bayesian and random forest modeling methods. These models were built based on patch clamp experimental results. The findings presented in this work indicate that Laplacian-modified naive Bayesian classification with diverse selection is useful for predicting hERG inhibitors when a large data set is not obtained.

[1]  A. Brown,et al.  Drugs, hERG and sudden death. , 2004, Cell calcium.

[2]  T. Nishikawa,et al.  A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors. , 2005, Bioorganic & medicinal chemistry letters.

[3]  Max K Leong,et al.  A novel approach using pharmacophore ensemble/support vector machine (PhE/SVM) for prediction of hERG liability. , 2007, Chemical research in toxicology.

[4]  W. Crumb,et al.  Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel. , 2002, The Journal of pharmacology and experimental therapeutics.

[5]  Alex M Aronov,et al.  Predictive in silico modeling for hERG channel blockers. , 2005, Drug discovery today.

[6]  Matthew Clark,et al.  Development and Evaluation of an in Silico Model for hERG Binding , 2006, J. Chem. Inf. Model..

[7]  A. Cavalli,et al.  Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers. , 2002, Journal of medicinal chemistry.

[8]  Gerhard F. Ecker,et al.  Classification Models for hERG Inhibitors by Counter‐Propagation Neural Networks , 2008, Chemical biology & drug design.

[9]  Meir Glick,et al.  Enrichment of High-Throughput Screening Data with Increasing Levels of Noise Using Support Vector Machines, Recursive Partitioning, and Laplacian-Modified Naive Bayesian Classifiers , 2006, J. Chem. Inf. Model..

[10]  G. Keserü.  Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. , 2003, Bioorganic & medicinal chemistry letters.

[11]  T J Campbell,et al.  HERG K+ channels: friend and foe. , 2001, Trends in pharmacological sciences.

[12]  R. Baierlein.  Probability Theory: The Logic of Science , 2004 .

[13]  Hongmao Sun,et al.  An Accurate and Interpretable Bayesian Classification Model for Prediction of hERG Liability , 2006, ChemMedChem.

[14]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[15]  Lupei Du,et al.  A novel structure-based virtual screening model for the hERG channel blockers. , 2007, Biochemical and biophysical research communications.

[16]  Roy J. Vaz,et al.  Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches. , 2003, Bioorganic & medicinal chemistry letters.

[17]  Jun Chen,et al.  A structural basis for drug-induced long QT syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Michael C Hutter,et al.  Determination of hERG channel blockers using a decision tree. , 2006, Bioorganic & medicinal chemistry.

[19]  Hongmao Sun,et al.  Support vector machines classification of hERG liabilities based on atom types. , 2008, Bioorganic & medicinal chemistry.